By Aman Jandu 
Discover what healthcare professionals (HCPs) think about pharmaceutical products and their manufacturers, as it happens, through CREATION.co’s tracking updates. How are HCPs responding to drug launch news? How are HCPs talking about or engaging with the Top 50 pharma companies on social media? Each week, CREATION.co’s tracking updates bring you the latest insights from the conversation of HCPs across the globe discussing these topics and more.
The Top 50 Pharmaceutical Companies mentioned by eHCPs on X
| July Rank | June Rank | Company Name | Total Mentions | Account Mentions | Account Retweets |
|---|---|---|---|---|---|
| 1 | 1 | Pfizer | 3,833 | 312 | 23 |
| 2 | 2 | Moderna | 1,879 | 131 | 7 |
| 3 | 3 | Johnson & Johnson | 797 | 416 | 8 |
| 4 | 4 | GSK | 496 | 180 | 27 |
| 5 | 5 | Lilly | 436 | 350 | 1 |
| 6 | 6 | Otsuka | 399 | 222 | 2 |
| 7 | 7 | AstraZeneca | 297 | 134 | 11 |
| 8 | 8 | Gilead Sciences | 290 | 103 | 5 |
| 9 | 9 | Abbott | 220 | 208 | 15 |
| 10 | 10 | BioNTech | 219 | 47 | 0 |
| 11 | 11 | Novo Nordisk | 217 | 136 | 8 |
| 12 | 12 | Roche | 216 | 68 | 19 |
| 13 | 12 | Bayer | 208 | 48 | 8 |
| 14 | 14 | Sanofi | 191 | 91 | 18 |
| 15 | 15 | Merck & Co | 167 | 74 | 5 |
| 16 | 16 | Novavax | 158 | 7 | 1 |
| 17 | 17 | BMS | 142 | 111 | 4 |
| 18 | 18 | Novartis | 134 | 57 | 4 |
| 19 | 19 | Biogen | 116 | 66 | 1 |
| 20 | 20 | Eisai | 112 | 88 | 0 |
| 21 | 21 | Takeda | 107 | 93 | 0 |
| 22 | 22 | AbbVie | 100 | 53 | 2 |
| 23 | 23 | Fresenius | 93 | 76 | 2 |
| 24 | 24 | Daiichi Sankyo | 76 | 6 | 2 |
| 25 | 25 | Boehringer Ingelheim | 61 | 43 | 4 |
| 26 | 26 | Amgen | 45 | 33 | 6 |
| 27 | 27 | Merck KGaA | 42 | 41 | 13 |
| 28 | 28 | Organon | 35 | 0 | 0 |
| 29 | 29 | Astellas | 27 | 19 | 0 |
| 29 | 30 | Regeneron | 27 | 9 | 1 |
| 31 | 31 | Horizon | 21 | 21 | 0 |
| 32 | 31 | Bausch | 18 | 3 | 0 |
| 33 | 33 | Teva | 12 | 12 | 0 |
| 34 | 34 | Grifols | 10 | 0 | 0 |
| 35 | 35 | Servier | 9 | 5 | 5 |
| 35 | 36 | Menarini | 9 | 8 | 2 |
| 37 | 37 | Sun | 8 | 7 | 2 |
| 37 | 38 | UCB | 8 | 6 | 0 |
| 37 | 39 | Ipsen | 8 | 1 | 0 |
| 37 | 40 | Viatris | 8 | 0 | 0 |
| 41 | 41 | Perrigo | 7 | 2 | 1 |
| 42 | 42 | CSL | 6 | 4 | 1 |
| 43 | 43 | Vertex | 3 | 3 | 1 |
| 44 | 43 | Incyte | 2 | 1 | 1 |
| 44 | 45 | Jazz Pharmaceuticals | 2 | 0 | 0 |
| 46 | 45 | Shanghai | 1 | 0 | 0 |
| 46 | 47 | CSPC | 1 | 0 | 0 |
| 46 | 50 | Sino | 1 | 0 | 0 |
| 50 | 50 | Chugai | 0 | 0 | 0 |
| 50 | 50 | Jiangsu Hengrui | 0 | 0 | 0 |
The latest insights from eHCPs mentioning the Top 50 Pharmaceutical Companies
The five pharmaceutical companies that were mentioned the most by eHCPs on X (Twitter) in July 2023 were Pfizer, Moderna, Johnson & Johnson, GSK and Lilly.
CREATION.co identified 10,143 eHCP mentions of pharmaceutical companies in July 2023, decreasing by just under 2% from the previous month.
A tornado with 150 mph wind speeds in North Carolina damaged a Pfizer facility on 20 July – generating a lot of eHCP conversation. It was believed that 50,000 pallets of medications were damaged at the time of reporting.
FYI – Pfizer factory in NC heavily damaged by a tornado. Current estimate – 50,000 pallets of medications damaged. Will impact the Pfizer supply chain & may lead to drug shortages for Pfizer products made at this plant. #medtwitter #TwitteRx #patients https://t.co/44BK4LJk0j
— Mary🦄 Gurney, RPh, PhD, BCPA, FAPhA (@rphteach) July 20, 2023
eHCPs took the opportunity to discuss the implications of the damage, with some stating that it could affect the availability of medicines for hospitals. The facility was responsible for the production of many different drugs, from anaesthetics to painkillers. Some eHCPs showed concern for potential shortages in the supply to US hospitals.
A tornado that ripped through a Pfizer plant raised worries about shortages of medicines used in hospitals. The medicines include commonly used painkillers and anesthetics.https://t.co/3JLkXe0sUa
— Ian Weissman, DO (@DrIanWeissman) July 28, 2023
Outside of the tornado conversation, many eHCPs posted about the news sharing the FDA had approved the Daiichi Sankyo product Vanflyta (quizartinib). The drug was approved for the treatment of acute myeloid leukaemia. The news was shared by 14 eHCPs following its approval on 20 July.
JUST IN: @US_FDAapproved quizartinib (Vanflyta, Daiichi Sankyo, Inc.) with standard cytarabine + anthracycline induction and cytarabine consolidation, and as maintenance for patients with newly diagnosed acute myeloid leukemia (AML) that is FLT3 internal tandem duplication… pic.twitter.com/CIzMStdJjg
— Toni Choueiri, MD (@DrChoueiri) July 20, 2023
Yanin Chávarri, an oncologist, shared a post thanking Pfizer and ASCO for their grants to improve cancer patient care for patients with metastatic breast cancer. Two other eHCPs also shared the post.
Very honored to receive this grant to improve cancer care for patients with Metastatic Breast Cancer in Mexico. Thanks to @ConquerCancerFd @ASCO and @pfizer grants.@incmnszmx @HemOncINCMNSZ https://t.co/1pZjpsgkJb
— Yanin Chávarri (@yaninchavarri) July 1, 2023
The top shared links by eHCPs when mentioning a Top 50 pharma company discussed:
- A YouTube video by an online news show discussing Bristol Myers Squibb’s product, Abilify.
- An article referring to the Novavax vaccine for SARS-CoV-2.
- An article discussing the production of Pfizer/BioNTech vaccines.
CREATION.co continues to analyse online eHCP conversation on a variety of topics including virtual congress, healthcare changes since the pandemic, product development and therapy area specific insights.
To stay up to date, you can sign up to CREATION.co’s monthly eJournal.
Methodology notes:
-
- In July 2023, CREATION Pinpoint® identified 10,143 healthcare professional authored posts on X (Twitter) from 4,057 individual eHCPs mentioning a Top 50 Pharmaceutical company (according to revenue).
- Data for this research was analysed from the online X conversations of eHCPs in all languages mentioning a Top 50 Pharmaceutical company between 01 July and 31 July 2023.
- Unless otherwise specified, mentions of a company are not limited to its X account(s).
- In some cases, an X post may mention more than one company account (e.g. @abbottnews and @abbottglobal) – this only counts as one Company Mention and Account Mention.
- Johnson & Johnson was included as a whole, encompassing its pharmaceutical subsidiary, Janssen. In July 2023, 208 of these posts mentioned Janssen.
Click here to view the latest Top 50 tracker
